You are viewing the site in preview mode

Skip to main content

Advertisement

Table 1 Clinically Evaluable Population

From: Switch therapy in hospitalized patients with community-acquired pneumonia: Tigecycline vs. Levofloxacin

Number of patients, n (%) Tigecycline (N = 138) Levofloxacin (N = 156) Total (N = 294)
Patients switched to oral therapy 124 (89.9%) 137 (87.8%) 261 (88.8%)
Patients not switched to oral therapy 14 (10.1%) 19 (12.2%) 33 (11.2%)
Patients meeting switch criteria as determined by present analysis 93 (67.4%) 104 (66.7%) 197 (67.0%)
Patients not meeting switch criteria as determined by present analysis 45 (32.6%) 52 (33.3%) 97 (33.0%)
Patients switched without meeting switch criteria as determined by present analysis 31 (22.5%) 33 (21.2%) 64 (21.8%)